1. Introduction {#s0005}
===============

Despite increasing evidence for structural brain alterations in obsessive-compulsive disorder (OCD) the overall picture has to be considered as rather heterogeneous with findings reporting both increases and decreases in gray matter volume, thickness, surface area or gyrification ([@bb0050], [@bb0125], [@bb0155], [@bb0165], [@bb0170], [@bb0175], [@bb0180], [@bb0195], [@bb0200]). In an attempt to reduce overall result heterogeneity and to filter out the most meaningful alterations, an increasing number of meta-analyses pooling data from multiple OCD sites worldwide are emerging in the OCD research community ([@bb0025], [@bb0035], [@bb0070]). The ENIGMA consortium analysis constitutes the largest meta-analysis on structural alterations in OCD to date. Employing a coordinated and standardized analysis approach, meta- and mega-analysis of data from 1830 OCD patients (*N* = 335 children, *N* = 1495 adults) and 1759 controls was conducted to identify alterations in subcortical brain volumes in OCD patients compared to healthy controls ([@bb0025]). As one of the main findings the analysis revealed the adult patient sample to have significantly increased pallidum and significantly smaller hippocampus volumes compared to healthy controls. The pallidum is regarded as one of the core regions within the frequently discussed cortico-striato-thalamo-cortical (CSTC) circuit. A dysbalance within this circuit is assumed to represent a central psychopathological mechanism underlying obsessions and compulsions in OCD. In contrast, the hippocampus has not been the focus of OCD psychopathophysiology up to now. Its volume, however, is frequently found to be decreased in other psychiatric disorders such as depression ([@bb0075], [@bb0140]) and PTSD ([@bb0005], [@bb0160]). One potential mechanism underlying volumetric changes in the hippocampus seems to be uncontrollable stress (i.e., stress perceived as distress) which is one of the main characteristics of many psychiatric disorders such as PTSD. Distress has been demonstrated to change neuronal morphology, suppress neuronal proliferation, and reduce hippocampal volume ([@bb0120]). According to ICD-10, OCD is classified as a stress-related disorder and patients with OCD tend to report high levels of stress and anxiety independent of their specific symptoms or symptom profiles ([@bb0185]). Therefore, there is strong reason to assume that hippocampal volume differences may be clinically relevant in OCD as well. Of note, the ENIGMA meta-analysis identified hippocampal volume differences to be larger in medicated patients, however, no relationship with symptoms was found. The ENIGMA study related volume differences to specific symptoms as assessed by the Y-BOCS checklist. However, it should be noted that the majority of all OCD patients are multi-symptomatic and the individual symptom profiles of OCD patients are heterogeneous to the extent that two patients may display different overlapping or even non-overlapping symptom patterns ([@bb0145]). Hence, instead of correlating outcome measures with specific symptoms one at a time, it may be reasonable to adopt an approach that accounts for possible interrelations of different symptom dimensions in patients. The fact that [@bb0025] found no significant correlations between symptom dimensions and hippocampus volumes is striking given the clear involvement of volume differences in patients found in their study. One possible explanation might be that symptom dimensions were related to structural alterations while controlling for the effects of other symptom dimensions, therefore effectively treating each symptom in isolation. To find out more about the clinical relevance of the recently reported differences in hippocampal structure, the present study employs a cluster analysis approach on dimensional symptoms to reach a differentiation into distinct symptom composition profiles, comparing hippocampal volumes between the different symptom profile groups. Thus, we aimed at exploring whether taking into account the interrelation between different symptoms, i.e., patients´ symptom composition profile, would be a valuable approach to relate structural alterations to clinically relevant features. We assumed that if the hippocampus would indeed be differentially affected in dependence on specific symptom composition profiles volume differences should be related to different symptom profiles. If hippocampus volumes would not be related to symptom profiles, this would rather speak in favor of a clinically unspecific hippocampal involvement in the disease.

2. Methods and materials {#s0010}
========================

2.1. Participants {#s0015}
-----------------

Data from two samples were combined. Sample one (S1) comprised *n* = 42 patients and *n* = 46 healthy controls and sample two (S2) comprised *n* = 24 patients and *n* = 20 healthy controls resulting in a total size of *n* = 66 patients with OCD as the primary diagnosis according to DSM-IV criteria and *n* = 66 healthy controls (see [Table 1](#t0005){ref-type="table"} for demographic and clinical details). Patients and controls were matched for sex and age in both samples. All patients were recruited from the Windach Institute and Hospital of Neurobehavioural Research and Therapy, Germany, and diagnoses were made by an experienced psychiatrist. Exclusion criteria for all participants were a history of clinically important head injuries, seizures or neurological diseases. At time of the study, *n* = 48 patients were drug-naive or medication free for at least 3 weeks and *n* = 30 patients had one or more comorbid diagnoses. To assess clinical severity of obsessive-compulsive symptoms, patients were administered the self-rated version of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) ([@bb0085], [@bb0095]). The Obsession-Compulsion Inventory revisited (OCI-R) ([@bb0065], [@bb0080]) was administered to more specifically assess different symptom dimensions. Additionally, depressive symptoms were evaluated based on the Beck Depression Inventory (BDI-II) ([@bb0020], [@bb0100]) in patients of sample S1 and the Hamilton Depression Scale (HAM-D) ([@bb0090]) in patients of sample S2. The study was approved by the local Ethics Committee of the Klinikum rechts der Isar, München and was conducted in accordance with the Declaration of Helsinki.Table 1Demographic and clinical sample characteristics.Table 1CharacteristicsOCDHC*nn*Mean ± SDMean ± SDSample size6666Female46 (69.7%)46 (69.7%)Age (years)32.4 ± 10.531.6 ± 10.3[‡](#tf0005){ref-type="table-fn"}Disease duration16.0 ± 10.8Y-BOCS total21.0 ± 6.2 Obsession11.0 ± 3.6 Compulsions9.9 ± 3.9OCI-R total25.4 ± 10.0 Hoarding2.3 ± 2.6 Checking5.5 ± 3.6 Ordering3.9 ± 3.8 Neutralizing2.2 ± 2.9 Washing4.8 ± 3.9 Obsessing6.8 ± 3.6BDI (S1)18.0 ± 11.5HAM-D (S2)12.6 ± 4.9Comorbidities30 (45.5%) Depression23 Anxiety disorder10 Personality disorder4 Eating disorder2 ADHD2Medication48 (72.7%) SSRI35 SSRNI6 Neuroleptic5 TCA3 Methylphenidate1 Benzodiazepine1 NDRI1 NaSSA1[^1][^2]

2.2. Image acquisition {#s0020}
----------------------

Magnetic resonance imaging was conducted on a 3T Philips Ingenia (Philips Healthcare, Best, The Netherlands) using a 12-channel (SENSE) head coil. For sample S1, structural imaging consisted of a T1-weighted 3D MPRAGE sequence with an isotropic resolution of 1 mm (170 slices, sagittal orientation, 240 × 240 matrix, TR = 9 ms, TE = 4 ms, flip angle = 8°) while for sample S2, imaging consisted of a T1-weighted 3D MPRAGE sequence with a resolution of 0.7 × 0.75 × 0.7 mm (230 slices, sagittal orientation, 368 × 340 matrix, TR = 11 ms, TE = 5.1 ms, flip angle = 8°). Prior to analysis the 24 submillimeter data sets of sample S2 were downsampled in order for all images to have a consistent resolution of 1 mm isotropic.

2.3. Image processing {#s0025}
---------------------

Based on these T1-weighted images, cortical and subcortical structures were initially segmented and labeled using Freesurfer (Version 6.0, <http://surfer.nmr.mgh.harvard.edu>/) ([@bb0030], [@bb0060], [@bb0055]). Processing included automatic segmentation into gray and white matter tissue compartments followed by parcellation of the gray matter mask into distinct brain regions and reconstruction of brain surfaces. These results were subsequently used to initialize the labeling of hippocampi using the recently released hippocampal subfield segmentation algorithm implemented in the Freesurfer package. Compared to previous versions, the labeling rests on an atlas which was built based on ex vivo MRI data of postmortem brain tissue acquired at 7T with sub-millimeter resolution and results have been shown to be in better agreement with histological studies ([@bb0115]). Hippocampus segmentations were visually inspected and volumes were quantitatively checked for outliers.

2.4. Symptom composition analysis (SCA) {#s0030}
---------------------------------------

In order to partition the patients according to their symptom composition, all OCI-R items were entered into a K-means cluster analysis in SPSS (IBM Corp. Released 2016. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp). This type of analysis allows to derive subgroups whose members are characterized by being rather similar in symptom composition within each subgroup while being as different as possible in symptom composition to members of other subgroups. The number of clusters (k) to be extracted was predefined to k = 3. This number was chosen in order to extract a number of clusters that allows for sufficient differentiability of patients while preserving a relatively large number of subjects per clusters (see Supplementary Fig. 1 for further details).

2.5. Statistical analysis {#s0035}
-------------------------

Demographic and clinical characteristics of subjects forming the three different clusters were compared using one-way ANOVAs with the respective demographic or clinical variable as dependent variable and cluster membership as factor with three factor levels. In line with [@bb0025] hippocampus volumes of the left and right hemisphere were averaged to yield a single hippocampus volume for each subject. For patients only, an ANCOVA model was fit to assess cluster-related differences in hippocampus volume while controlling for the following covariates: age, sex, total intracranial volume, OCI-total score, depression, medication, disease duration, and scanner. Controlling for OCI-total scores allows the assessment of potential effects of cluster membership irrespective of cluster-specific differences in global OCI symptom severity. Medication was entered as a dichotomous variable indicating whether patients were medication naïve or medication free for at least three weeks prior to scanning. HAM-D and BDI scores were transformed into a dichotomous variable and used as a proxy to indicate the absence or presence of clinically relevant depressive symptoms. HAM-D scores ≥ 9 and BDI scores ≥ 13 were considered to indicate the presence of relevant depressive symptoms according to the German National Disease Management Guideline Depression ([@bb0040]). In a second analysis, potential cluster-related differences in hippocampus volumes between patients and healthy controls were assessed. To this end, an ANCOVA model was fit treating all healthy controls as belonging to one synthetic cluster of their own resulting in the factor cluster with four levels. Additionally, the analysis was controlled for the following covariates: age, sex, and total intracranial volume.

3. Results {#s0040}
==========

3.1. Symptom composition analysis (SCA) {#s0045}
---------------------------------------

The mean scores of each OCI-R item according to cluster membership are depicted in [Fig. 1](#f0005){ref-type="fig"}A. Items are grouped together according to OCI symptom scales. ANOVA analyses revealed a significant main effect of cluster on OCI total score (F(2,63) = 34.924, *p* \< 0.001, corrected). Information regarding demographic characteristics and statistical differences between each patient cluster are depicted in [Table 2](#t0010){ref-type="table"}.Fig. 1Symptom profile composition and hippocampal volumes. Symptom composition analysis (A): Mean scores of each OCI-R item according to cluster membership, grouped by symptom dimensions. Numbers in parentheses indicate the number of each item in the questionnaire. Within patients analysis (B): Marginal means ± standard error. There was a significant main effect of cluster membership on global hippocampal volume while controlling for age, sex, total intracranial volume, total OCI-R score, clinically relevant depression, medication, disease duration and scanner (F(2,55) = 3.301, *p* = 0.044). Between groups analysis (C): Marginal means ± standard error. There was a significant main effect of cluster on global hippocampal volume while controlling for age, sex, and total intracranial volume (F(3,125) = 4.752, *p* = 0.004).Fig. 1Table 2Demographic and clinical sample characteristics in the three patient groups.Table 2CharacteristicsCluster 1Cluster 2Cluster 3F-statistic*p*-ValueMean ± SDMean ± SDMean ± SDn(%)n(%)n(%)OCI total23.47 ± 8.6534.12 ± 6.4617.67 ± 6.1334.924\< 0.001[⁎](#tf0010){ref-type="table-fn"}Age31.38 ± 11.2033.63 ± 11.0631.90 ± 9.720.2660.767Disease duration12.88 ± 6.6118.92 ± 13.5915.04 ± 9.581.7420.184Male1 (5.9%)9 (36.0%)10 (41.7%)3.5310.035Depression9 (52.9%)21 (84%)17 (70.8%)2.4510.094Medication15 (88.2%)20 (80.0%)14 (58.3%)2.7790.070[^3]

3.2. Hippocampus volume {#s0050}
-----------------------

### 3.2.1. Within patients analysis {#s0055}

There was a significant main effect of cluster on global hippocampus volume while controlling for age, sex, total intracranial volume, total OCI-R score, clinically relevant depression, medication, disease duration, and scanner (F(2,55) = 3.301, *p* = 0.044, η^2^ = 0.057). Additionally, there was a significant main effect of sex (F(1,55) = 6.429, *p* = 0.014, η^2^ = 0.055), total intracranial volume (F(1,55) = 7.291, *p* = 0.009, η^2^ = 0.063), presence or absence of clinically relevant depression (F(1,55) = 5.613, *p* = 0.021, η^2^ = 0.048) and scanner (F(1,55) = 5.354, *p* = 0.024, η^2^ = 0.017) (see [Fig. 1](#f0005){ref-type="fig"}B as well as [Table 3](#t0015){ref-type="table"}). Post-hoc tests indicated that hippocampus volume was significantly different between cluster 2 and 3 (*p* = 0.020, 95% CI \[− 562.77, − 49.47\]) while there was a trend significant difference between cluster 1 and 3 (*p* = 0.056, 95% CI \[− 432.59, 5.75\]) and no significant difference between clusters 1 and 2 (*p* = 0.456, 95% CI \[− 154.82, 340.21\]). For exploratory analyses of hippocampus subfield volumes see Supplementary Table I.Table 3ANCOVA model details for within patients analysis.Table 3Sum of squares (Typ III)dfMean squaresFSignificanceη^2^Partial η^2^Corrected model5,342,274.9510534,227.506.107\< 0.0010.526Constant term3,484,000.1013,484,000.1039.829\< 0.0010.420Cluster577,495.262288,747.633.3010.044[⁎](#tf0015){ref-type="table-fn"}0.0570.107Age27,210.95127,210.950.3110.5790.0030.006Sex562,325.531562,325.536.4290.014[⁎](#tf0015){ref-type="table-fn"}0.0550.105ICV637,788.241637,788.247.2910.009[⁎](#tf0015){ref-type="table-fn"}0.0630.117OCI total11,522.83111,522.830.1320.7180.0010.002Depression490,991.261490,991.265.6130.021[⁎](#tf0015){ref-type="table-fn"}0.0480.093Medication16,746.94116,746.940.1910.6630.0020.003Disease duration66,142.75166,142.750.7560.3880.0070.014Scanner168,298.301168,298.305.3540.024[⁎](#tf0015){ref-type="table-fn"}0.0170.089Error4,811,035.055587,473.37Total812,213,858.7066Corrected total variation10,153,310.0065[^4]

### 3.2.2. Between groups analysis {#s0060}

There was a significant main effect of cluster on global hippocampus volume while controlling for age, sex, total intracranial volume and scanner (F(3,125) = 4.752, *p* = 0.004, η^2^ = 0.071). Additionally, there was a significant main effect of sex (F(1,125) = 10.914 *p* = 0.001, η^2^ = 0.081), total intracranial volume (F(1,125) = 17.758 *p* \< 0.001, η^2^ = 0.088) and scanner (F(1,125) = 6.797 *p* = 0.010, η^2^ = 0.034) (see [Fig. 1](#f0005){ref-type="fig"}C as well as [Table 4](#t0020){ref-type="table"}). Post-hoc tests were conducted to compare each patient cluster with healthy controls (c1 vs. HC, c2 vs. HC, c3 vs. HC). For this comparison alpha was Bonferroni-corrected to be α = 0.05/3 or α = 0.017. Cluster 2 was found to be significantly different from HC (*p* = 0.012, 95% CI \[− 297.39, − 37.47\]). Differences between cluster 3 and healthy controls (*p* = 0.063, 95% CI \[− 255.23, 6.75\]) as well as between cluster 1 and HC were not significant (*p* = 0.366, 95% CI \[− 82.68, 222.46\]).Table 4ANCOVA model details for between groups analysis.Table 4Sum of squares (Typ III)dfMean squaresFSignificanceη^2^Partial η^2^Corrected model5,882,377.337840,339.61811.003\< 0.0010.383Constant term9,327,886.0319,327,886.03122.130\< 0.0010.496Cluster1,088,735.903362,911.974.7520.004[⁎](#tf0020){ref-type="table-fn"}0.0710.103Age6681.4216681.420.0870.768\< 0.0010.001Sex833,600.241833,600.2410.9140.001[⁎](#tf0020){ref-type="table-fn"}0.0540.081ICV1,356,312.6811,356,312.6817.758\< 0.001[⁎](#tf0020){ref-type="table-fn"}0.0880.125scanner519,145.231519,145.236.7970.010[⁎](#tf0020){ref-type="table-fn"}0.0340.052Error9,470,732.1912476,376.87Total1,647,001,109.00132Corrected total variation15,353,109.51131[^5]

4. Discussion {#s0065}
=============

To find out more about the clinical relevance of hippocampal volume changes in OCD, in the present study we categorized a large sample of OCD patients into three distinct symptom profiles and compared alterations in hippocampal volume between the resulting groups. We further compared the resulting clusters with healthy participants. With this procedure we aimed at further elucidating the clinical significance of hippocampal volume alterations by better accounting for the clinical heterogeneity of the disorder. The cluster analysis showed that the relatively large patient sample could be subdivided most adequately into three symptom profile groups. Common to all clusters was the moderate to high level of obsessing symptoms. This feature thus does not seem be the major driving factor regarding hippocampus volume differences. Similar, but less pronounced are the dimensions neutralizing and hoarding. Here, the overall symptom strength is low to moderate with slight differences between clusters. The main differences between clusters could be found for the dimensions washing, ordering, and checking. Here cluster 1 revealed by far the highest washing scores while being on par with cluster 3 on ordering and checking symptoms. Cluster 2 revealed intermediate washing symptoms while scoring the highest on ordering as well as checking symptoms. On a side note, cluster 1, characterized by the highest washing symptoms, contained only a single male patient and 16 female patients. This is in line with earlier studies reporting washing symptoms predominantly in female patients ([@bb0130], [@bb0150], [@bb0190]). As a main finding the present analysis demonstrated that hippocampus volume differed significantly between the three groups with post-hoc tests indicating that cluster 2 had significantly smaller hippocampal volumes than cluster 3. Importantly, this result was corrected for the influence of overall symptom severity (i.e., OCI-R total score) which indicates that the respective symptom profiles account for variation in hippocampal volume independent of overall symptom severity. Hence, present findings clearly demonstrate that the classification into different OCD symptom profiles -- an approach which has been recommended already years ago ([@bb0145]) -- significantly accounts for variation in hippocampal volume reduction. Additionally, there was a difference between hippocampal volumes when including a group of healthy subjects, with post-hoc tests indicating significant differences between cluster 2 and healthy controls. Present findings moreover extend recent results from the currently largest meta-analysis on structural alterations in OCD (i.e., the ENIGMA consortium meta-analysis) which revealed significantly smaller hippocampal volumes in adult OCD patients compared to healthy controls ([@bb0025]). The meta-analysis showed the effect to be stronger in medicated patients compared to controls but not significantly related to clinical symptoms. However, unlike in the present study, in this meta-analysis symptom spectra or the interrelation between different symptoms was not taken into account but symptoms were assessed independently for each Y-BOCS checklist symptom dimension. Present findings not only corroborate the clinical relevance of hippocampal volume alterations in OCD as reported before ([@bb0105]) but strongly suggest that the interrelation of symptom dimensions should be taken into account in this regard. As also shown in [Fig. 1](#f0005){ref-type="fig"}A, it seems that a high severity of mainly ordering and checking symptoms (i.e., cluster 2) may be predominantly indicative of a reduction in hippocampus volume. The hippocampus is a highly stress-sensitive structure ([@bb0120]) and is often found to be reduced in volume in other stress-related disorders such as depression ([@bb0135]) and PTSD ([@bb0005]). Hence, there is reason to assume that the association between a high level of predominantly ordering/checking (cluster 2) and - to a somewhat lesser extent predominantly washing (cluster 1) symptoms - and reduced hippocampal volume may be mediated via stress and stress-related physiological processes going along with these symptom profiles and their associated behavior. In this context it is interesting to note that the association remained significant even after correcting for the comorbidity of depression. Moreover, the association between symptom profile and hippocampal volume also remained significant after correcting for the influence of disease duration. In this case, disease duration did not have a significant effect on hippocampal volume. This finding seems to contradict the above formulated assumption that stress going along with the disorder may play a relevant role in this context. However, findings from meta-analyses on hippocampal volumes in depression produced relatively conflicting results and suggested that disease duration may be a significant influencing factor mainly in elderly patients ([@bb0045]) (i.e., hippocampal degenerative processes due to disorder-related stress may become manifest predominantly in elderly patients who had been suffering from depression for various years). Of note, the average disease duration between clusters was not significantly different, i.e., overall effects of disease duration had no significant influence on this type of analysis. This finding does therefore not rule out the possibility of disease duration related effects on hippocampal volumes in general. Apart from the above mentioned meta-analysis ([@bb0025]) which showed a significantly decreased hippocampal volume in patients with OCD, a limited amount of previous studies already reported alterations in hippocampus structure and neurochemistry in patients with OCD. For instance, [@bb0105] found a decreased hippocampal volume in OCD patients employing voxel-based analyses and [@bb0110] observed a bilateral hippocampal shape deformity in OCD patients compared to healthy controls when performing a shape analysis of the hippocampus. Regarding hippocampal neurochemistry lower hippocampal ratio of *N*-acetyl-[l]{.smallcaps}-aspartate/choline (NAA/CHO) which is considered to indicate loss of neurons and axons has been reported in patients with OCD ([@bb0010]). Interestingly, follow-up studies found these alterations to partly normalize by effective treatment and clinical improvement ([@bb0015]). Hence, our finding that patients with a symptom profile characterized by a high level of predominantly checking/ordering symptoms (cluster 2) showed stronger hippocampal volume differences compared to patients without a high severity in any specific domain as well as an overall lower symptom severity (cluster 3) complements these results. Taken together, present and earlier findings suggest that alterations in hippocampal volume in terms of neuroplasticity or partial reversal of tissue loss may be an indicator of treatment-related clinical improvement whereas hippocampal volume in terms of volumetric loss may represent a state marker of disease severity if assessed dimensionally according to specific symptom spectra or the interrelation between specific symptom dimensions. Longitudinal study designs might further elucidate an interaction between attenuation of strength in symptom profiles due to therapy and associated hippocampus volume changes.

5. Limitations {#s0070}
==============

In opposition to the results of the currently largest meta-analysis ([@bb0025]) which found that hippocampal volume reductions were stronger in medicated patients compared to controls we only found a trend significant influence of medication on volumes. These partly conflicting findings may have mainly statistical reasons as it must be assumed that the meta-analysis based on a sample of 1495 adult OCD patients had considerably larger detection power than the present study. The definition of clinically relevant depression was based on two different questionnaires (self-rated and clinician-rated) resulting from the aggregation of two different samples. Therefore, the factor depression should be assessed in further studies using the same questionnaires for the definition of cut-offs.
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[^1]: Note that multiple comorbid diagnoses as well as different medication types can be present in a single patient; abbreviations for medication: NaSSA, noradrenergic and specific serotonergic antidepressant; NDRI, norepinephrine-dopamine reuptake inhibitor; SSNRI, selective serotonin-norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.

[^2]: Two-sample *t*-test (t(130) = 0.442, *p* = 0.659).

[^3]: *p* \< 0.05, Bonferroni-corrected for the total number of ANOVAs computed.

[^4]: =* p* \< 0.05;

    ANCOVA model formulation:

    hippo~vol~ = 2697.20 − 213.42^∗^ clust~1~ − 306.12^∗^ clust~2~ − 3.18^∗^ age + 275.47^∗^ sex + 0.001^∗^ ICV + 2.09^∗^ OCI~total~ − 204.19^∗^ depression + 38.93^∗^ medication + 5.14^∗^ disease duration + 231.78^∗^ scanner.

[^5]: =* p* \< 0.05;

    ANCOVA model formulation:

    hippo~vol~ = 2534.54 − 69.89^∗^ clust~1~ − 167.43^∗^ clust~2~ + 124.29^∗^ clust~3~ + 0.70^∗^ age + 200.56^∗^ sex + 0.001^∗^ ICV + 159.60^∗^ scanner.
